Title:
USE OF PYRIDINE DERIVATIVE WHICH IS TRPV1 ANTAGONIST
Document Type and Number:
WIPO Patent Application WO/2024/095962
Kind Code:
A1
Abstract:
The present invention provides a novel pharmaceutical composition and a method for treating and/or preventing social impairment, such as autism spectrum disorder, fragile X syndrome, and/or autism spectrum-like symptoms. Specifically, provided is a pharmaceutical composition for the treatment and/or prevention of social impairment, the pharmaceutical composition comprising a compound represented by formula (I) (in the formula, R1 is a substituted or unsubstituted alkyl; R2 is a hydrogen atom or the like; A is N or the like; the dashed line represents the presence or absence of a bond; R3 is a substituted or unsubstituted alkyl or the like; m is 0 or 1; and R4 and R5 each independently represent a hydrogen atom or the like) or a pharmaceutically acceptable complex thereof.
Inventors:
YAMAKAWA HIDEKUNI (JP)
Application Number:
PCT/JP2023/039098
Publication Date:
May 10, 2024
Filing Date:
October 30, 2023
Export Citation:
Assignee:
SHIONOGI & CO (JP)
International Classes:
A61K31/496; A61P25/00
Domestic Patent References:
| WO2008132600A2 | 2008-11-06 | |||
| WO2011162409A1 | 2011-12-29 | |||
| WO2012158844A1 | 2012-11-22 |
Foreign References:
| EP3443956A1 | 2019-02-20 |
Attorney, Agent or Firm:
YAMAO, Norihito et al. (JP)
Download PDF: